Plasmon resonance coupling of metal nanoparticles for molecular imaging of carcinogenesis in vivo

Jesse Aaron, Nitin Nitin, Kort Travis, Sonia Kumar, Tom Collier, Sun Young Park, Miguel José-Yacamán, Lezlee Coghlan, Michele Follen, Rebecca Richards-Kortum, Konstantin Sokolov

Research output: Contribution to journalArticle

156 Citations (Scopus)

Abstract

An effective cancer control strategy requires improved early detection methods, patient-specific drug selection, and the ability to assess response to targeted therapeutics. Recently, plasmon resonance coupling between closely spaced metal nanoparticles has been used to develop ultrasensitive bioanalytical assays in vitro. We demonstrate the first in vivo application of plasmon coupling for molecular imaging of carcinogenesis. We describe molecular-specific gold bioconjugates to image epidermal growth factor receptor (EGFR); these conjugates can be delivered topically and imaged noninvasively in real time. We show that labeling with gold bioconjugates gives information on the overexpression and nanoscale spatial relationship of EGF receptors in cell membranes, both of which are altered in neoplasia. EGFR-mediated aggregation of gold nanoparticles in neoplastic cells results in more than a 100-nm color shift and a contrast ratio of more than tenfold in images of normal and precancerous epithelium in vivo, dramatically increasing contrast beyond values reported previously for antibody-targeted fluorescent dyes.

Original languageEnglish (US)
Article number034007
JournalJournal of Biomedical Optics
Volume12
Issue number3
DOIs
StatePublished - May 2007
Externally publishedYes

Fingerprint

Metal Nanoparticles
Molecular imaging
Molecular Imaging
Metal nanoparticles
Gold
Carcinogenesis
gold
Epidermal Growth Factor Receptor
nanoparticles
metals
epithelium
Cell membranes
antibodies
Fluorescent Dyes
Antibodies
Nanoparticles
Labeling
marking
Assays
Neoplasms

Keywords

  • Early detection
  • Epidermal growth factor receptor (EGFR)
  • Metal nanoparticles
  • Optical imaging
  • Plasmon coupling

ASJC Scopus subject areas

  • Biomedical Engineering
  • Biomaterials
  • Electronic, Optical and Magnetic Materials
  • Atomic and Molecular Physics, and Optics
  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology
  • Clinical Biochemistry

Cite this

Aaron, J., Nitin, N., Travis, K., Kumar, S., Collier, T., Park, S. Y., ... Sokolov, K. (2007). Plasmon resonance coupling of metal nanoparticles for molecular imaging of carcinogenesis in vivo. Journal of Biomedical Optics, 12(3), [034007]. https://doi.org/10.1117/1.2737351

Plasmon resonance coupling of metal nanoparticles for molecular imaging of carcinogenesis in vivo. / Aaron, Jesse; Nitin, Nitin; Travis, Kort; Kumar, Sonia; Collier, Tom; Park, Sun Young; José-Yacamán, Miguel; Coghlan, Lezlee; Follen, Michele; Richards-Kortum, Rebecca; Sokolov, Konstantin.

In: Journal of Biomedical Optics, Vol. 12, No. 3, 034007, 05.2007.

Research output: Contribution to journalArticle

Aaron, J, Nitin, N, Travis, K, Kumar, S, Collier, T, Park, SY, José-Yacamán, M, Coghlan, L, Follen, M, Richards-Kortum, R & Sokolov, K 2007, 'Plasmon resonance coupling of metal nanoparticles for molecular imaging of carcinogenesis in vivo', Journal of Biomedical Optics, vol. 12, no. 3, 034007. https://doi.org/10.1117/1.2737351
Aaron, Jesse ; Nitin, Nitin ; Travis, Kort ; Kumar, Sonia ; Collier, Tom ; Park, Sun Young ; José-Yacamán, Miguel ; Coghlan, Lezlee ; Follen, Michele ; Richards-Kortum, Rebecca ; Sokolov, Konstantin. / Plasmon resonance coupling of metal nanoparticles for molecular imaging of carcinogenesis in vivo. In: Journal of Biomedical Optics. 2007 ; Vol. 12, No. 3.
@article{adf0f80894014116a096a37909f1b852,
title = "Plasmon resonance coupling of metal nanoparticles for molecular imaging of carcinogenesis in vivo",
abstract = "An effective cancer control strategy requires improved early detection methods, patient-specific drug selection, and the ability to assess response to targeted therapeutics. Recently, plasmon resonance coupling between closely spaced metal nanoparticles has been used to develop ultrasensitive bioanalytical assays in vitro. We demonstrate the first in vivo application of plasmon coupling for molecular imaging of carcinogenesis. We describe molecular-specific gold bioconjugates to image epidermal growth factor receptor (EGFR); these conjugates can be delivered topically and imaged noninvasively in real time. We show that labeling with gold bioconjugates gives information on the overexpression and nanoscale spatial relationship of EGF receptors in cell membranes, both of which are altered in neoplasia. EGFR-mediated aggregation of gold nanoparticles in neoplastic cells results in more than a 100-nm color shift and a contrast ratio of more than tenfold in images of normal and precancerous epithelium in vivo, dramatically increasing contrast beyond values reported previously for antibody-targeted fluorescent dyes.",
keywords = "Early detection, Epidermal growth factor receptor (EGFR), Metal nanoparticles, Optical imaging, Plasmon coupling",
author = "Jesse Aaron and Nitin Nitin and Kort Travis and Sonia Kumar and Tom Collier and Park, {Sun Young} and Miguel Jos{\'e}-Yacam{\'a}n and Lezlee Coghlan and Michele Follen and Rebecca Richards-Kortum and Konstantin Sokolov",
year = "2007",
month = "5",
doi = "10.1117/1.2737351",
language = "English (US)",
volume = "12",
journal = "Journal of Biomedical Optics",
issn = "1083-3668",
publisher = "SPIE",
number = "3",

}

TY - JOUR

T1 - Plasmon resonance coupling of metal nanoparticles for molecular imaging of carcinogenesis in vivo

AU - Aaron, Jesse

AU - Nitin, Nitin

AU - Travis, Kort

AU - Kumar, Sonia

AU - Collier, Tom

AU - Park, Sun Young

AU - José-Yacamán, Miguel

AU - Coghlan, Lezlee

AU - Follen, Michele

AU - Richards-Kortum, Rebecca

AU - Sokolov, Konstantin

PY - 2007/5

Y1 - 2007/5

N2 - An effective cancer control strategy requires improved early detection methods, patient-specific drug selection, and the ability to assess response to targeted therapeutics. Recently, plasmon resonance coupling between closely spaced metal nanoparticles has been used to develop ultrasensitive bioanalytical assays in vitro. We demonstrate the first in vivo application of plasmon coupling for molecular imaging of carcinogenesis. We describe molecular-specific gold bioconjugates to image epidermal growth factor receptor (EGFR); these conjugates can be delivered topically and imaged noninvasively in real time. We show that labeling with gold bioconjugates gives information on the overexpression and nanoscale spatial relationship of EGF receptors in cell membranes, both of which are altered in neoplasia. EGFR-mediated aggregation of gold nanoparticles in neoplastic cells results in more than a 100-nm color shift and a contrast ratio of more than tenfold in images of normal and precancerous epithelium in vivo, dramatically increasing contrast beyond values reported previously for antibody-targeted fluorescent dyes.

AB - An effective cancer control strategy requires improved early detection methods, patient-specific drug selection, and the ability to assess response to targeted therapeutics. Recently, plasmon resonance coupling between closely spaced metal nanoparticles has been used to develop ultrasensitive bioanalytical assays in vitro. We demonstrate the first in vivo application of plasmon coupling for molecular imaging of carcinogenesis. We describe molecular-specific gold bioconjugates to image epidermal growth factor receptor (EGFR); these conjugates can be delivered topically and imaged noninvasively in real time. We show that labeling with gold bioconjugates gives information on the overexpression and nanoscale spatial relationship of EGF receptors in cell membranes, both of which are altered in neoplasia. EGFR-mediated aggregation of gold nanoparticles in neoplastic cells results in more than a 100-nm color shift and a contrast ratio of more than tenfold in images of normal and precancerous epithelium in vivo, dramatically increasing contrast beyond values reported previously for antibody-targeted fluorescent dyes.

KW - Early detection

KW - Epidermal growth factor receptor (EGFR)

KW - Metal nanoparticles

KW - Optical imaging

KW - Plasmon coupling

UR - http://www.scopus.com/inward/record.url?scp=34547126107&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547126107&partnerID=8YFLogxK

U2 - 10.1117/1.2737351

DO - 10.1117/1.2737351

M3 - Article

VL - 12

JO - Journal of Biomedical Optics

JF - Journal of Biomedical Optics

SN - 1083-3668

IS - 3

M1 - 034007

ER -